Recently published work demonstrated that elevated non-canonical ATM signaling is capable of inducing EMT in cisplatin-resistant NSCLC cell lines by upregulating JAK/STAT3 signaling and enhancing PD-L1 expression [8]. The gene discussed is ATM; the disease is non-small cell lung carcinoma.